REFERENCES:

1. Salik I, Marwaha R. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL):

Sep 19, 2022. Electroconvulsive Therapy.
2. Singh R, Volner K, Marlowe D. StatPearls [Internet]. StatPearls Publishing; Treasure
Island (FL): Jun 21, 2022. Provider Burnout.
3. Ormel J, Kessler RC, Schoevers R. Depression: more treatment but no drop in
prevalence: how effective is treatment? And can we do better? Curr Opin
Psychiatry. 2019 Jul;32(4):348-354.
4. Pham TH, Gardier AM. Fast-acting antidepressant activity of ketamine: highlights on
brain serotonin, glutamate, and GABA neurotransmission in preclinical
studies. Pharmacol Ther. 2019 Jul;199:58-90.
5. Namkung H, Lee BJ, Sawa A. Causal Inference on Pathophysiological Mediators in
Psychiatry. Cold Spring Harb Symp Quant Biol. 2018;83:17-23.
6. Mangla K, Hoffman MC, Trumpff C, O'Grady S, Monk C. Maternal self-harm deaths:
an unrecognized and preventable outcome. Am J Obstet Gynecol. 2019
Oct;221(4):295-303.
7. Shelton RC. Serotonin and Norepinephrine Reuptake Inhibitors. Handb Exp
Pharmacol. 2019;250:145-180.
8. Tanner J, Zeffiro T, Wyss D, Perron N, Rufer M, Mueller-Pfeiffer C. Psychiatric
Symptom Profiles Predict Functional Impairment. Front Psychiatry. 2019;10:37.
9. Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal
symptoms. Lancet Psychiatry. 2019 Jun;6(6):538-546.
10. Knappe S, Einsle F, Rummel-Kluge C, Heinz I, Wieder G, Venz J, Schouler-Ocak M,
Wittchen HU, Lieb R, Hoye J, Schmitt J, Bergmann A, Beesdo-Baum K. [Simple
guideline-oriented supportive tools in primary care: Effects on adherence to the
S3/NV guideline unipolar depression]. Z Psychosom Med Psychother. 2018
Sep;64(3):298-311.
11. Saracino RM, Nelson CJ. Identification and treatment of depressive disorders in older
adults with cancer. J Geriatr Oncol. 2019 Sep;10(5):680-684.
12. Hengartner MP, Passalacqua S, Andreae A, Heinsius T, Hepp U, Rössler W, von Wyl
A. Antidepressant Use During Acute Inpatient Care Is Associated With an Increased
Risk of Psychiatric Rehospitalisation Over a 12-Month Follow-Up After
Discharge. Front Psychiatry. 2019;10:79.
13. Rootes-Murdy K, Carlucci M, Tibbs M, Wachtel LE, Sherman MF, Zandi PP, Reti
IM. Non-suicidal self-injury and electroconvulsive therapy: Outcomes in adolescent
and young adult populations. J Affect Disord. 2019 May 01;250:94-98.
14. Liu Q, He H, Yang J, Feng X, Zhao F, Lyu J. Changes in the global burden of
depression from 1990 to 2017: Findings from the Global Burden of Disease study.
Journal of psychiatric research. 2020 Jul 1;126:134-40.
15. Pilania M, Bairwa M, Kumar N, Khanna P, Kurana H. Elderly depression in India: An
emerging public health challenge. The Australasian medical journal. 2013;6(3):107.
16. Cai H, Jin Y, Liu R, Zhang Q, Su Z, Ungvari GS, Tang YL, Ng CH, Li XH, Xiang
YT. Global prevalence of depression in older adults: A systematic review and meta-
analysis of epidemiological surveys. Asian Journal of Psychiatry. 2022 Dec
20:103417.
17. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annual
review of public health. 2013 Mar 18;34:119-38.
18. Miller AH, Raison CL. Immune system contributions to the pathophysiology of
depression. Focus. 2008 Jan;6(1):36-45.
19. Tubbs JD, Ding J, Baum L, Sham PC. Immune dysregulation in depression: Evidence
from genome-wide association. Brain, Behavior, & Immunity-Health. 2020 Aug
1;7:100108.
20. Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD.
Inflammatory markers in depression: a meta-analysis of mean differences and
variability in 5,166 patients and 5,083 controls. Brain, behavior, and immunity. 2020
Jul 1;87:901-9.
21. Dinan TG. Inflammatory markers in depression. Current opinion in psychiatry. 2009
Jan 1;22(1):32-6.
22. Brigitta B. Pathophysiology of depression and mechanisms of treatment. Dialogues in
clinical neuroscience. 2002 Mar 31.
23. Zhu J, Jin J, Tang J. Inflammatory pathophysiological mechanisms implicated in
postpartum depression. Frontiers in Pharmacology. 2022 Nov 3;13:955672.
24. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the
pathogenesis of depression. Trends in immunology. 2006 Jan 1;27(1):24-31.
25. Miller AH, Raison CL. Immune system contributions to the pathophysiology of
depression. Focus. 2008 Jan;6(1):36-45.
26. Dionisie V, Filip GA, Manea MC, Movileanu RC, Moisa E, Manea M, Riga S,
 Ciobanu AM. Neutrophil-to-lymphocyte ratio, a novel inflammatory marker, as a
predictor of bipolar type in depressed patients: a quest for biological markers. Journal
of clinical medicine. 2021 Apr 29;10(9):1924.
27. Cheng Y, Wang Y, Wang X, Jiang Z, Zhu L, Fang S. Neutrophil-to-lymphocyte ratio,
platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in depression: an
updated systematic review and meta-analysis. Frontiers in Psychiatry. 2022 Jun
15;13:893097.
28. Chamberlain SR, Cavanagh J, De Boer P, Mondelli V, Jones DN, Drevets WC,
Cowen PJ, Harrison NA, Pointon L, Pariante CM, Bullmore ET. Treatment-resistant
depression and peripheral C-reactive protein. The British Journal of Psychiatry. 2019
Jan;214(1):11-9.
29. Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance.
Atherosclerosis Supplements. 2005 May 1;6(2):21-9.
30. Abraham BP, Thirumurthi S. Clinical significance of inflammatory markers. Current
gastroenterology reports. 2009 Oct;11(5):360-7.
31. Erjavec GN, Sagud M, Perkovic MN, Strac DS, Konjevod M, Tudor L, Uzun S, Pivac
N. Depression: Biological markers and treatment. Progress in Neuro-
Psychopharmacology and Biological Psychiatry. 2021 Mar 8;105:110139.
32. Reynolds EH, Kinnier Wilson JV. Obsessive compulsive disorder and psychopathic
behaviour in Babylon. J Neurol Neurosurg Psychiatry 2012; 83: 199–201.
33. Tipton CM. The history of "Exercise Is Medicine" in ancient civilizations. Adv
Physiol Educ. 2014;38(2):109–117.
34. Tesarova D. Aulus Cornelius Celsus and a regimen. Cas Lek Cesk. 2018;157(5):263-
267.
35. Tabatabaei SM, Jafari-Mehdiabad A. Rhazes' pioneer viewpoints about psychiatry,
neurology and neuroscience. J Med Ethics Hist Med. 2020 Dec 12;13:21.
36. Brink A. Depression and loss: A theme in Robert Burton's "Anatomy of Melancholy"
(1621). Can J Psychiatry. 1979;24(8):767-72.
37. Rossler W. The stigma of mental disorders: A millennia-long history of social
exclusion and prejudices. EMBO Rep. 2016 Sep;17(9):1250-3.
38. Pluskota A. The application of positive psychology in the practice of education.
Springerplus. 2014;3:147. doi:10.1186/2193-1801-3-147.
39. Mavissakalian M, Perel J, Guo S. Specific side effects of long-term imipramine
management of panic disorder. J Clin Psychopharmacol. 2002;22(2):155-61.
40. Depression - National Institute of Mental Health
(NIMH).[Link]
41. World Health Organization. Depression: key facts [Internet]. Geneva: WHO; 2024
[cited 2024 Jul 13]. Available from:
[Link]
42. GBD 2023 Diseases and Injuries Collaborators. Global Burden of Disease Study 2023
(GBD 2023) Results. Seattle, WA: Institute for Health Metrics and Evaluation
(IHME); 2024. Available from: [Link]
43. Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, et al. Global
variation in the prevalence and incidence of major depressive disorder: a systematic
review of the epidemiological literature. Psychol Med. 2013;43(3):471-81.
44. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, et al.
Cross-national epidemiology of DSM-IV major depressive episode. BMC Med.
2011;9:90.
45. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al.
Prevalence of mental disorders in Europe: results from the European Study of the
Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl.
2004;(420):21-7.
46. Steel Z, Chey T, Silove D, Marnane C, Bryant RA, van Ommeren M. Association of
torture and other potentially traumatic events with mental health outcomes among
populations exposed to mass conflict and displacement: a systematic review and
meta-analysis. JAMA. 2009;302(5):537-49.
47. Gururaj G, Varghese M, Benegal V, Rao GN, Pathak K, Singh LK, et al. National
Mental Health Survey of India, 2015-16: prevalence, patterns and outcomes.
Bengaluru: National Institute of Mental Health and Neuro Sciences, NIMHANS
Publication No. 129, 2016.
48. Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders:
a systematic review and meta-regression. Psychol Med. 2013;43(5):897-910.
49. Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, et al.
Use of mental health services for anxiety, mood, and substance disorders in 17
countries in the WHO world mental health surveys. Lancet. 2007;370(9590):841-50.
50. National Institute of Mental Health and Neuro Sciences (NIMHANS). National
Mental Health Survey of India, 2015-16. Bengaluru: NIMHANS; 2016.
51. Meitei KT, Singh HS. Prevalence of Depression Among Indian Population. Online J
 Health Allied Scs. 2019;18(4):12.
52. Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, et al. Addressing
the burden of mental, neurological, and substance use disorders: key messages from
Disease Control Priorities, 3rd edition. Lancet. 2016; 387(10028):1672-85.
53. Ganguly S, Samanta M, Roy P, Chatterjee S, Kaplan DW, Basu B. PHQ-9 as an
effective tool for screening of depression among Indian adolescents. J Adolesc
Health. 2013;52:546-551.
54. Chauhan P, Kokiwar PR, Shridevi K, Katkuri S. A study on prevalence and correlates
of depression among elderly population of rural South India. Int J Community Med
Public Health [Internet]. 2017;3(1):236-9.
55. Saha A, Mandal B, Muhammad T, Ali W. Decomposing the rural–urban differences
in depression among multimorbid older patients in India: evidence from a cross-
sectional study. BMC Psychiatry. 2024;24(1):60.
56. Pawar N, Kumar N, Vikram A, Sembiah S, Rajawat G. Depression and its socio-
demographic correlates among urban slum dwellers of North India: A cross-sectional
study. J Family Med Prim Care. 2022;11(6):2369-2376.
57. Paul R, Muhammad T, Rashmi R, Sharma P, Srivastava S, Zanwar PP. Depression by
gender and associated factors among older adults in India: implications for age-
friendly policies. Sci Rep. 2023;13(1):17651.
58. Hanspal I, Krishnaswamy P, Rose M, Mary T, Antony J, Johnson AR. How prevalent
is depression among rural school-going adolescents: A cross-sectional study in South
Karnataka. Journal of Indian Association for Child and Adolescent Mental Health.
2019;15(2):124-139.
59. World Health Organization. The ICD-10 classification of mental and behavioural
disorders: Diagnostic criteria for research. Geneva: World Health Organization; 1993.
xiii+248p.
60. American Psychiatric Association. Diagnostic and statistical manual of mental
disorders (DSM-5®). American Psychiatric Publishing; 2013.
61. World Health Organization. ICD-11 - Mortality and Morbidity Statistics [Internet].
Vol. 11. World Health Organization; 2018 [cited 2024 Jul 14]. Available from:
[Link]
62. World Health Organization. Fact sheets [Internet]. Geneva: World Health
Organization; [2023 Mar 31; cited 2024 Jul 14]. Available from:
[Link]
63. Lam LCW, Wong CSM, Wang MJ, Chan WC, Chen EYH, Ng RMK, et al.
Prevalence, psychosocial correlates and service utilization of depressive and anxiety
disorders in Hong Kong: the Hong Kong Mental Morbidity Survey (HKMMS). Soc
Psychiatry Psychiatr Epidemiol. 2015;50(9):1379-1388.
64. John CN, Gergues MM, Samuels BA. The role of 5-HT receptors in depression. Mol
Brain. 2017;10:28.
65. Chu A, Wadhwa R. Selective Serotonin Reuptake Inhibitors. In: StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Updated 2023 May 1.
Available from: [Link]
66. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA.
Reduced levels of norepinephrine transporters in the locus coeruleus in major
depression. J Neurosci. 1997;17(21):8451-8.
67. Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related
deficits. Trends Neurosci. 2012;35(2):68-77.
68. Belujon P, Grace AA. Dopamine system dysregulation in major depressive disorders.
Int J Neuropsychopharmacol. 2017;20(12):1036-1046.
69. Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J
Clin Psychiatry. 2000;61:4–6.
70. Brown SL, Bleich A, Van Praag HM. The Monoamine Hypothesis of Depression: The
Case for Serotonin. In: Role Of Serotonin In Psychiatric Disorders. 1st ed. Routledge;
1991:38. doi:9781315825861.
71. Chockalingam R, Gott BM, Conway CR. Tricyclic Antidepressants and Monoamine
Oxidase Inhibitors: Are They Too Old for a New Look? Handb Exp Pharmacol.
2019;250:37-48.
72. Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and
glutamate neurotransmitter deficits and reversal by novel treatments. Neuron.
2019;102(1):75-90.
73. Narayan GA, Hill KR, Wengler K, He X, Wang J, Yang J, et al. Does the change in
glutamate to GABA ratio correlate with change in depression severity? A randomized,
double-blind clinical trial. Mol Psychiatry. 2022;27:3833-3841.
74. Zhang FF, Peng W, Sweeney JA, Jia ZY, Gong QY. Brain structure alterations in
depression: Psychoradiological evidence. CNS Neurosci Ther. 2018;24(11):994-1003.
75. Chan SWY, Harmer CJ, Norbury R, O'Sullivan U, Goodwin GM, Portella MJ.
Hippocampal volume in vulnerability and resilience to depression. J Affect Disord.
 2016;189:199-202.
76. Sheline Y. I. Depression and the hippocampus: cause or effect? Biological Psychiatry.
2011;70(4):308–309.
77. Sung YH, Shin MS, Cho S, Baik HH, Jin BK, Chang HK, et al. Depression-like state
in maternal rats induced by repeated separation of pups is accompanied by a decrease
of cell proliferation and an increase of apoptosis in the hippocampus. Neurosci Lett.
2010;470(1):86-90.
78. Saleh A, Potter GG, McQuoid DR, Boyd B, Turner R, MacFall JR, et al. Effects of
early life stress on depression, cognitive performance and brain morphology. Psychol
Med. 2017;47(1):171-181.
79. Booth BD, Gulati S. Mental illness and sexual offending. Psychiatr Clin North Am.
2014;37:183-194.
80. Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH, et al.
Increased stress-induced inflammatory responses in male patients with major
depression and increased early life stress. Am J Psychiatry. 2006;163:1630-1633.
81. Danese A, Lewis SJ. Psychoneuroimmunology of early-life stress: the hidden wounds
of childhood trauma? Neuropsychopharmacology. 2017;42:99-114.
82. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders:
the emerging picture and its implications. Nat Rev Genet. 2012;13(8):537-51.
83. Meng L, Bai X, Zheng Y, Chen D, Zheng Y. Altered expression of norepinephrine
transporter participate in hypertension and depression through regulated TNF-α and
IL-6. Clin Exp Hypertens. 2019;42(2):181-189.
84. McGowan PO, Sasaki A, D’Alessio AC, Dymov S, Labonté B, Szyf M, et al.
Epigenetic regulation of the glucocorticoid receptor in human brain associates with
childhood abuse. Nat Neurosci. 2009;12:342-348.
85. Chen ES, Ernst C, Turecki G. The epigenetic effects of antidepressant treatment on
human prefrontal cortex BDNF expression. Int J Neuropsychopharmacol.
2011;14:427–9.
86. Cruceanu C, Alda M, Nagy C, Freemantle E, Rouleau GA, Turecki G. H3K4 tri-
methylation in synapsin genes leads to different expression patterns in bipolar
disorder and major depression. Int J Neuropsychopharmacol. 2013;16:289–99.
87. Koene S, Kozicz TL, Rodenburg RJ, Verhaak CM, de Vries MC, Wortmann S, et al.
Major depression in adolescent children consecutively diagnosed with mitochondrial
disorder. J Affect Disord. 2009;114:327-332.
88. Lotrich FE. Inflammatory cytokine-associated depression. Brain Res. 2015;1617:113-
125.
89. Capuron L, Schroecksnadel S, Féart C, Aubert A, Higueret D, Barberger-Gateau P, et
al. Chronic low-grade inflammation in elderly persons is associated with altered
tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol
Psychiatry. 2011;70(2):175-182.
90. Talarowska M, Bobińska K, Zajączkowska M, Su KP, Maes M, Gałecki P. Impact of
oxidative/nitrosative stress and inflammation on cognitive functions in patients with
recurrent depressive disorders. Med. Sci. Monit. 2014; 20: 110–115.
91. Gałecki P, Talarowska M. Inflammatory theory of depression. Psychiatr Pol.
2018;52(3):437-447.
92. Muthuramalingam A, Menon V, Rajkumar RP, Negi VS. Is Depression an
Inflammatory Disease? Findings from a Cross-sectional Study at a Tertiary Care
Center. Indian Journal of Psychological Medicine. 2016;38(2):114-119.
93. Liu X, Zheng P, Zhao X, Zhang Y, Hu C, Li J, et al. Discovery and validation of
plasma biomarkers for major depressive disorder classification based on liquid
chromatography–mass spectrometry. J Proteome Res. 2015;14(5):2322-2330.
94. Mandal S, Spoorthy MS, Godi SM, Nanda R, Mukherjee B, Mishra NR.
Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective,
Clinic-Based, Cohort Study From India. Cureus. 2023;15(8):e43059.
95. Halaris A, Prochaska D, Stefanski A, Filip M. C-reactive protein in major depressive
disorder: Promise and challenge. J Affect Disord Rep. 2022 Dec;10:100427.
96. Lamers F, Milaneschi Y, Smit JH, Schoevers RA, Wittenberg G, Penninx BWJH.
Longitudinal association between depression and inflammatory markers: results from
the Netherlands Study of Depression and Anxiety. Biol Psychiatry. 2019 May
15;85(10):829-837.
97. Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD.
Inflammatory markers in depression: A meta-analysis of mean differences and
variability in 5,166 patients and 5,083 controls. Brain Behav Immun. 2020;87:901-
909.
98. Shi R, Gwee X, Chua DQL, Tan CTY, Yap KB, Larbi A, et al. Inflammatory markers
and incident depression: Evidence in a population-based prospective study.
Psychoneuroendocrinology. 2022;142:105806
99. Ji Y, Wang J, Chen H, Li J, Chen M. Association between hs-CRP and depressive
symptoms: a cross-sectional study. Front Psychiatry. 2024;15:1339208. doi:
10.3389/fpsyt.2024.1339208.
100. Nicaise E, Schmeusser BN, Biermann H, Ali A, Ambadi S, Patil DH, et al. The
association of C-reactive protein with major depressive symptoms in nonmetastatic
renal cell carcinoma. J Psychosoc Oncol Res Pract. 2023;5(4):117.
101. Orsolini L, Pompili S, Tempia Valenta S, Salvi V, Volpe U. C-Reactive Protein as a
Biomarker for Major Depressive Disorder? Int J Mol Sci. 2022;23(3):1616.
102. Pitharouli MC, Hagenaars SP, Glanville KP, Coleman JRI, Hotopf M, Lewis CM, et
al. Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic,
Health, and Psychosocial Factors: Results From the UK Biobank. Am J Psychiatry.
2021;178:522-529.
103. Almeida OP, Norman P, Hankey GJ, Jamrozik K, Flicker L. The association
between C-reactive protein concentration and depression in later life is due to poor
physical health: results from the Health in Men Study (HIMS). Psychological
Medicine. 2007;37(12):1775-1786.

104. Mishra D, Sardesai U, Razdan R. C-reactive protein level in late-onset depression: A

case–control study. Indian J Psychiatry. 2018;60(4):467-471
105. Kinoshita H, Takekawa D, Kudo T, Sawada K, Mikami T, Hirota [Link]
neutrophil–lymphocyte ratio is associated with depressive symptoms in Japanese
general male population. Sci Rep. 2022;12:9268. [Link]
13562-x.
106. Brinn A, Stone J. Neutrophil–lymphocyte ratio across psychiatric diagnoses: a cross-
sectional study using electronic health records. BMJ Open. 2020;10. doi:
10.1136/bmjopen-2020-036859.

107. Adhikari A, Dikshit R, Karia S, Sonavane S, Shah N, De Sousa A. Neutrophil-

lymphocyte ratio and C-reactive protein level in patients with major depressive
disorder before and after pharmacotherapy. East Asian Arch Psychiatry.
2018;28(2):53-58.)
108. YR NH, Hegde SG, Mathew T. Neutrophil-to-lymphocyte ratio, platelet-to-
lymphocyte ratio and their association with the severity of depression and as
 biomarkers for suicidal behaviour among patients diagnosed with depression. Journal
of Krishna Institute of Medical Sciences (JKIMSU). 2023 Oct 1;12(4).).
109. Zhou X, Li Y, Sun Z, Mu L, Ma Y. Elevated red blood cell distribution width levels
predict depression after intracerebral hemorrhage: A 3-month follow-up study. Front
Neurol. 2023;14:1077518.
110. Dai M, Wei Q, Zhang Y, Fang C, Qu P, Cao L. Predictive value of red blood cell
distribution width in poststroke depression. Comput Math Methods Med.
2021;2021:8361504. doi: 10.1155/2021/8361504.